Preservation of C-peptide after diagnosis of type 1 diabetes (T1D) is associated with lower risk of both hypoglycemia and long-term microvascular complications. The decline of C-peptide after T1D onset is highly variable among subjects. The goal of this study was to evaluate factors associated with the rate of C-peptide decline. TEDDY participants identified at birth with high-risk HLA genotype and followed regularly until T1D diagnosis (n=70) and 60 age-matched children diagnosed with T1D in the community (median age at diagnosis = 6.7 years, IQR 5.1-7.9) were enrolled in a 2-year follow-up with mixed meal tolerance tests at 1, 3, 6, 12 and 24 months. Mixed effects models for repeated measures were used adjusting for age at diagnosis and C-peptide at baseline. In univariate analyses, factors associated with rate of C-peptide loss included sex, age at diagnosis, baseline BMI, AUC C-peptide, HbA1c, IA-2A positivity and ZnT8A positivity. Four of these 7 factors remained significant in multivariate analysis (all p ≤ 0.037, see Table). Younger age at diagnosis, higher HbA1c, IA-2A positivity and ZnT8A positivity were associated with higher rate of C-peptide decline in this young cohort of children diagnosed with T1D.


A. Steck: None. X. Liu: None. J. Krischer: None. M.J. Haller: Advisory Panel; Self; Pancreum, SAB Biotherapeutics. R. Veijola: None. B. Akolkar: None. J. Toppari: None. W. Hagopian: Research Support; Self; Novo Nordisk A/S. M. Rewers: None. H. Elding Larsson: None.


JDRF; National Institutes of Health

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at